T Sugiyama, Y Hasuo, T Nishida, T Kamura. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AgedAntineoplastic Combined Chemotherapy Protocols/therapeutic useCamptothecin/administration & dosageCamptothecin/analogs & derivativesCarcinoma, Adenosquamous/drug therapyCarcinoma, Adenosquamous/surgeryCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/surgeryCisplatin/administration & dosageClinical Trials, Phase II as TopicDisease-Free SurvivalFemaleHumansIrinotecanMiddle AgedNeoadjuvant TherapyNeoplasm StagingPeplomycin/administration & dosageUterine Cervical Neoplasms/drug therapyUterine Cervical Neoplasms/radiotherapyUterine Cervical Neoplasms/surgery
Substances： See more » PeplomycinIrinotecanCisplatinCamptothecin
Year: 2001 PMID： 11330973 DOI： 10.1006/gyno.2001.6169
Source DB: PubMed Journal: Gynecol Oncol ISSN： 0090-8258 Impact factor: 5.482